Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders - ScienceDirect
Table 1 from Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. | Semantic Scholar
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies | Current Addiction Reports
Opioid receptor subtypes: fact or artifact? - British Journal of Anaesthesia
The Role of Opioids and Their Receptors in Urological Malignancy: A Review
κ-opioid receptor - Wikipedia
Biased signaling by endogenous opioid peptides | PNAS
Figure 2 from Development of κ opioid receptor antagonists. | Semantic Scholar
Opioids in cancer: The κ‑opioid receptor (Review)
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Frontiers | Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions | Molecular Pharmacology
IJMS | Free Full-Text | Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
Ligand and G-protein selectivity in the κ-opioid receptor | Nature
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports